Metoprolol, a selective beta 1-adrenoreceptor blocker, was administered
to two patients with intermittent explosive disorder who had not done well
with previous medications, including propranolol and carbamazepine. Both
patients improved dramatically, suggesting clinical and theoretical
relevance.
Abstract Teaser